Clinical Trials on Familial Primary Hyperparathyroidism in Switzerland
Total 1003 results
-
University Hospital Inselspital, BerneCompletedPrimary HyperparathyroidismSwitzerland
-
Centre Hospitalier Universitaire VaudoisThe Novartis FoundationRecruiting
-
University Hospital, GenevaCompleted
-
Michel BurnierCompletedHyperparathyroidism | Chronic Kidney DiseaseSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedMetabolic Syndrome | Familial Combined Hyperlipidemia | Familial HypertriglyceridemiaSwitzerland
-
NovartisCompletedMixed Dyslipidemia | Heterozygous Familial HypercholesterolemiaSwitzerland
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
Idorsia Pharmaceuticals Ltd.TerminatedPulmonary Arterial HypertensionUnited States, France, Switzerland
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
Center for Primary Care and Public Health (Unisante)...Swiss Heart FoundationCompletedFamilial HypercholesterolemiaSwitzerland
-
University of Lausanne HospitalsCompletedNasal Obstruction | Lumbar Stenosis, FamilialSwitzerland
-
University Hospital Inselspital, BerneRecruitingCerebral Small Vessel Diseases | Intracerebral Hemorrhage | CAA - Cerebral Amyloid AngiopathySwitzerland
-
ActelionCompletedPulmonary Arterial HypertensionUnited States, France, Netherlands, Italy, Germany, Switzerland, United Kingdom
-
ActelionCompletedPulmonary Arterial HypertensionUnited States, France, Netherlands, Italy, Germany, Switzerland, United Kingdom
-
University Hospital Inselspital, BerneRecruitingCerebral Amyloid Angiopathy | Cadasil | Small Vessel Cerebrovascular Disease | CAA - Cerebral Amyloid AngiopathySwitzerland
-
Novartis PharmaceuticalsTerminatedPulmonary Arterial HypertensionSwitzerland, United States, Germany, Singapore, Korea, Republic of, Canada
-
CENTOGENE GmbH RostockAlnylam PharmaceuticalsRecruitingCardiomyopathies | Polyneuropathies | Transthyretin Amyloidosis | Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid PolyneuropathyGermany, Austria, Switzerland
-
Heidelberg UniversityMerck Sharp & Dohme LLCRecruitingSystemic Sclerosis | Pulmonary Vascular Disorder | Primary Pulmonary Hypertension | Other Systemic Involvement of Connective TissueAustria, Germany, Italy, France, Switzerland
-
University of Geneva, SwitzerlandTerminated22q11.2 Deletion SyndromeSwitzerland
-
University of Geneva, SwitzerlandCompleted22q11.2 Deletion SyndromeSwitzerland
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
-
Stephan EliezRecruitingtACS | 22Q11 Deletion SyndromeSwitzerland
-
Zurich University of Applied SciencesCompleted
-
Novartis PharmaceuticalsRecruitingHeterozygous or Homozygous Familial HypercholesterolemiaNetherlands, Israel, Hungary, Italy, Germany, Spain, United States, France, Norway, Russian Federation, South Africa, Turkey, United Kingdom, Canada, Switzerland, Brazil, Lebanon, Slovenia, Poland, Taiwan, Malaysia
-
University Hospital, Basel, SwitzerlandCompletedPrimary Vascular DysregulationSwitzerland
-
Insel Gruppe AG, University Hospital BernUniversity of BernRecruiting
-
ActelionCompletedPulmonary Arterial HypertensionUnited States, United Kingdom, Ireland, Germany, Austria, France, Norway, Portugal, Sweden, Switzerland
-
University of BernSwiss Federal Institute of TechnologyCompletedStress | Primary Prevention | Adult | Tai jiSwitzerland
-
Kantonsspital GraubuendenKlinik Hirslanden, ZurichCompletedNeoplasms, Second PrimarySwitzerland
-
University Hospital Inselspital, BerneTerminatedInfertility | Ovarian Failure, PrematureSwitzerland
-
ActelionCompletedPulmonary Arterial HypertensionUnited States, Spain, Denmark, Canada, Germany, United Kingdom, Belgium, Austria, Netherlands, Australia, France, Ireland, Sweden, Italy, Switzerland
-
University of ZurichRecruiting
-
University of ZurichRecruiting
-
University Hospital, Basel, SwitzerlandCompletedPrimary PolydipsiaSwitzerland
-
Novartis PharmaceuticalsTerminatedPulmonary Arterial HypertensionSpain, Germany, Belgium, Switzerland, United States, Netherlands, Austria, Canada, Korea, Republic of, Italy, Japan, United Kingdom, France
-
University of ZurichPD Dr. med. Verena Geissbühler; Prof. pharm. Ursula von Mandach; Dr. med. David... and other collaboratorsTerminatedOveractive Bladder | Urge Urinary IncontinenceSwitzerland
-
AmgenCompletedFamilial HypercholesterolemiaCanada, Italy, Norway, Belgium, United States, Turkey, Australia, Austria, South Africa, Poland, Switzerland, Spain, Portugal, Slovenia, Brazil, Russian Federation, Hungary, United Kingdom, Colombia, Czechia, Netherlands, Greece, Ma...
-
Max Zeller Soehne AGCompletedThe Primary Condition Studied for This Trial is Acute StressSwitzerland
-
University of ZurichUniversity Hospital Tuebingen; Salzburger LandesklinikenCompletedUrinary Stress IncontinenceSwitzerland
-
Insel Gruppe AG, University Hospital BernUniversity of BernRecruitingStatin Treatment for Primary PreventionSwitzerland
-
Oxys Medical AGUnknownUrinary InfectionsSwitzerland
-
University Hospital Inselspital, BerneCompletedUrodynamics | Acute Urinary RetentionSwitzerland
-
University of ZurichCompletedStress Urinary IncontinenceSwitzerland
-
David ScheinerUniversity of ZurichTerminated
-
Novartis PharmaceuticalsCompletedPulmonary Arterial HypertensionUnited States, Switzerland, Germany, Belgium, Spain, United Kingdom, Italy, Korea, Republic of, Netherlands, Canada, Sweden, Austria, Japan, France
-
University of ZurichCompletedOveractive Bladder SyndromeSwitzerland
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive BladderSwitzerland
-
Prof. Dr. med. Marc PossoverUnknownBladder, OveractiveSwitzerland
-
University of ZurichCompleted
-
University Hospital Inselspital, BerneCompletedBladder Cancer | Urinary DiversionSwitzerland